Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma (Flu-Mel-Vel)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2015 by Hackensack University Medical Center
Information provided by (Responsible Party):
Hackensack University Medical Center Identifier:
First received: October 13, 2011
Last updated: August 21, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)